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Acute oral toxicityAbstract Swietenia macrophylla (SM) is a medicinally important plant found in tropical and sub-
tropical regions of the world. The ethyl acetate fraction of the seeds of S. macrophylla (SMEAF) is
reported to exhibit potent anticancer, antitumor, anti-inflammatory and antifeedant activities. Till
date, there have been no studies reported on the acute oral toxicity profile of the ethyl acetate frac-
tion of the seeds of SM. The objective of the present study was to determine the acute toxicity of
SMEAF and evaluate the in-vitro neuroprotective activity of SMEAF using primary neuronal cell
cultures. In acute oral toxicity study, the SMEAF did not produce any lethal signs of morbidity and
mortality. Histo-pathological findings, support the safety of SMEAF, as there were no significant
changes observed in any of the parameters studied. Based on the results obtained in MTT assay,
we infer that SMEAF has a significant neuroprotective effect, as it increased the cell viability
and exhibited protection to the neuronal cells against TBHP induced oxidative stress. Thus,
SMEAF can be suggested for use in the development of herbal drug formulations with neuropro-
tective potential.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).50 5709
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2 M. Sayyad et al.1. Introduction
Medicines from natural origin have been used as a source of
remedy for the prevention, cure and treatment of different ail-
ments in Traditional Systems of Medicine (TSMs) (Rates,
2001). Therapeutically important plants in TSMs have been
extensively explored recently, for their benefits and various
applications in herbal health supplements (Borris, 1996;
Gurib-Fakim, 2006; Katiyar et al., 2012). The World Health
Organization – Traditional medicine strategy published
recently states that traditional and Complementary medicines
have gained a growing economic importance worldwide
(Anon., 2013).
Swietenia macrophylla plant is an important medicinal
plant indigenous to tropical and subtropical regions of the
world, and it belongs to Meliaceae family. It is considered as
one of the functional foods in Malaysia. Literature survey
reveals publications that report the presence of limonoids, swi-
etenioides, methyl angolensate and diacetyl swietenioides (Goh
et al., 2010; Goh and Kadir, 2011; Mootoo et al., 1999). Tra-
ditionally, the seeds have been used as anti-hypertensive, anti-
diabetic and anti-inflammatory agents (King et al., 2013).
Commercially, the fruits have been used in the formulation
of health products for blood circulation (Eid and El-
Enshasy, 2013). S. macrophylla has also been reported for its
hypolipidemic, anti-infective, anticancer, antimicrobial, and
antidiarrheal effect (Goh et al., 2010; Kalpana and
Pugalendi, 2011). In a recent study, the ethanolic extract of
S. macrophylla fruits has been reported to possess potential
neuropharmacological benefits with positive antinociceptive
effect (Das, 2009). The objective of the present study was to
investigate the acute oral toxicity profile of ethyl acetate frac-
tion from S. macrophylla seed extract (SMEAF) in murine
models and evaluate the neuroprotective potential of SMEAF
using primary neuronal culture. The acute toxicity study was
carried out in mice, as per the standard protocol of the Orga-
nization for Economic Cooperation and Development
(OECD) guidelines.
2. Materials and methods
2.1. Plant material and preparation of crude extracts
The dried seeds of the S. macrophylla (500 g) were procured
from the local market and authenticated, and a voucher spec-
imen (No. KLU046901) was deposited in the Herbarium of
Institute of Biological Sciences, Faculty of Science, University
of Malaya, Malaysia.
The crude extract was prepared, after soaking 500 g of
ground sample in ethanol for 72 h with occasional stirring at
room temperature. The extraction solvent was then decanted
and concentrated using a rotary vacuum evaporator at 40 C.
The obtained extract was further extracted with n-hexane
repeatedly. The obtained n-hexane extracts were combined,
dried with anhydrous sodium sulfate, filtered and concentrated
with a rotary vacuum evaporator. The hexane insoluble residue
was then subjected to solvent–solvent extraction and partition-
ing using ethyl acetate and water in the ratio of 1:1. Both layers
were separated, filtered and evaporated to dryness to obtainPlease cite this article in press as: Sayyad, M. et al., Acute toxicity profiling of the et
studies. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.0ethyl acetate and aqueous fractions. The dried ethyl acetate
fraction was dissolved in DMSO and used for acute oral toxic-
ity and neuroprotection studies (Supriady et al., 2015).
2.2. Animals
Toxicity study was conducted on 12 healthy male Balb/c mice,
with body weights ranging between 18 and 22 g, with age of
about 7 weeks. Animals were obtained from the animal facility
of Monash University Malaysia and maintained under stan-
dard husbandry conditions such as temperature 25 ± 2 C, rel-
ative humidity of 50 ± 10%, 12 h light and dark cycle, stress
free environment and provided with standard diet and sanitary
conditions. All the experimental procedures related to the ani-
mal study, were approved by Monash University Animal Eth-
ical Committee (MARP/2015/040) and were conducted
following the standard protocol for animal use and care.
BALB/c mice were selected for this study, as several studies
have reported this strain as a good strain for toxicity evalua-
tion. Also, the merits of using BALB/c mice in toxicity studies
include their attributes, like low incidence of mammary
tumors, longer life spans, resistance to development of
atherosclerosis due to dietary factors and good responses in
the production of monoclonal antibodies (Heshu et al., 2014;
Potter, 1985).
2.3. Acute oral toxicity study and LD50 determination
The OECD guideline number 425 up and down procedure is
used to minimize the number of animals required for acute oral
toxicity testing. In the present study, OECD guideline no. 425
was employed for the determination of LD50 value of SMEAF
and changes in general behavior were evaluated according to
the Irwin test (Roux et al., 2004). The mice were distributed
into two groups, SMEAF and control (OECD, 1994). Animals
were fasted overnight before the experiment, and were admin-
istered with a single dose of SMEAF (2000 mg/kg)/vehicle and
observed for various behaviors described in Irwin test. Special
attention was given to first 4 h, followed by 24 h monitoring
for any signs of morbidity and mortality. Based on the results
of the short-profile study of the extract, the dose of the next
group of animals was determined as per the OECD guideline
no. 425. The LD50 of the test extract was calculated using
AOT 425 software provided by the Environmental Protection
Agency (EPA), USA.
2.3.1. Clinical observations, body weight, water and food
consumption
After the administration of a single dose of SMEAF, mice
were observed initially for 4 h for any abnormal clinical signs
and once daily for 14 days. The parameters were recorded
for both, the treatment and control groups (Roux et al., 2004).
All the mice were observed and recorded daily for changes
in posture, skin, fur, eyes, behavior, morbidity and mortality
as per Irwin’s test. On the first day before treatment, the body
weight of animals was measured and recorded, followed by
daily observations and recording thereafter, prior to necropsy.
Food and water consumption was measured and recorded on a
daily basis throughout the duration and prior to necropsy.hyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection
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Toxicity study and neuroprotective activity of Swietenia macrophylla 32.3.2. Hematological and biochemical studies
Hematological and biochemical studies were performed by
using the standard method as described by Jothy et al.
(2011). On the 15th day, animals were anesthetized to collect
blood samples for hematological and biochemical analysis.
No mortality was recorded as all the animals from both the
groups survived till the end of the study period. Mice were
fasted overnight prior to blood collection. Before carrying
out necropsy procedure, all the mice were weighed and eutha-
nized by CO2 asphyxia. Immediately after euthanization,
500 lL of blood sample was collected from each animal
through cardiac puncture into both EDTA – containing and
non-heparinized tubes for hematological and biochemical
analyses, respectively.
The hematology studies were carried out for complete
blood count (CBC) which includes hemoglobin levels (HGB),
hematocrit levels (HCT), mean cell hemoglobin levels
(MCH), mean cell hemoglobin concentration (MCHC), mean
corpuscular volume (MCV), red blood cell count (RBC), white
blood cell count (WBC), and blood platelet count (PLT). It
also includes a differential count i.e.; neutrophil (N), lympho-
cyte (L), monocyte (M), eosinophil (E), basophil (B), and
immature granulocyte (G).
The biochemical measurements included liver and kidney
function tests. Liver function test involved estimation of total
protein (TP), albumin (ALB), globulin (GLOB), total bilirubin
(TB), conjugated bilirubin (CB), alkaline phosphatase (ALK),
G-glutamyl transferase (GT), alanine aminotransferase (ALT),
and aspartate aminotransferase (AST).
2.3.3. Necropsy and histopathology
After the collection of the blood for hematology and biochem-
istry studies, the animals were decapitated and vital organs
were excised and weighed. The vital organs include brain,
heart, lungs, kidney, lever, spleen and testes.
All the seven vital organs collected, were transferred to
10% formalin for fixation and then embedded into paraffin
to prepare paraffin blocks and sectioned with a semi automatic
rotary microtome. Tissue sections of thickness 5 lm of major
isolated organs were taken, later stained with hematoxylin
and eosin (H and E) and observed under an optical microscope
(Olympus, Tokyo, Japan).
2.4. Neuroprotection studies
2.4.1. Primary neuronal culture
Primary neuronal culture for cortex neurons was obtained
from rat pups (day 3–5) using a standard protocol with minor
modifications of the method described in Pacifici and Peruzzi
(2012). Briefly, the brains were dissected out and kept in ice
cold Krebs buffer until the separation of cortex region. Krebs
buffer was comprised of NaCl, 126; CaCl2 2.5; KCL 2.5;
NaHCO3 25; MgCl26H2O, 1.2; NaH2PO42H2O 1.2; and Glu-
cose 11, in milli Molar concentrations. Cortex regions were
then incubated for 15 min in trypsin (0.25%) at 37 C followed
by washing twice with Krebs buffer solution at 37 C. Each
washing was carried out for 5 min. Finally, the cell pellet
was suspended in small quantity of Krebs buffer with 0.1%
DNase. The cell number in the filtrate was determined by using
hemocytometer and cells were plated with culture media in 12
well culture plates (2 mL/well), which were precoated withPlease cite this article in press as: Sayyad, M. et al., Acute toxicity profiling of the et
studies. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.0poly-D-lysine. Neuron cells were plated at a density of
0.5  106 cells/mL (50% density) and maintained at 37 C in
a CO2 incubator for 7–8 days for the development of the cells.
Every third day, culture was changed to serum-free Neu-
robasal media containing 1  B27, 0.5 mM L-glutamine,
0.01 lg/mL streptomycin, and 100 U/mL penicillin.
2.4.2. MTT assay
MTT (3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium
Bromide) assay was performed by using the standard method
as described by Shin et al. with minor modification (Shin
et al., 2009). In brief, confluent cortex primary neuronal cells
were seeded into the sterile flat bottom 96-well plate and
allowed to adhere for 24 h. Cells were treated with 1 lg/mL,
10 lg/mL, and 30 lg/mL SMEAF for 2 h prior to TBHP
(tert-Butyl hydroperoxide) exposure (0.001 mM) for 24 h.
Twenty microliters of MTT solution was added to each well
and the plate was further incubated at 37 C in CO2 for 4 h.
After 4 h of incubation, the solution was removed and
100 lL of DMSO (Dimethyl sulfoxide) was added to each well.
The absorbance was measured spectrophotometrically using a
microplate reader and percentage viability was calculated.
2.5. Statistical analysis
All the data were analyzed using Statistical Package for Social
Sciences (SPSS) version 22.0. Data are represented as Mean
± SEM. Statistical analyses were performed using t-test and
one-way ANOVA, and p values less than 5% were considered
statistically significant (p< 0.05).3. Results
3.1. Acute oral toxicity and LD50 determination
There were no mortalities in the present study. At termination,
all the animals (6/6; 100%) survived at 2000 mg/kg dose
including vehicle control (6/6, 100%). The LD50 value for
SMEAF was calculated to be >2000 mg/kg.
3.2. Clinical observations, body weight, water and food
consumption
In this study, SMEAF 2000 mg/kg treatment did not exhibit
any abnormal clinical signs on the general behavioral pattern
of mice. No toxic signs and symptoms or mortality was
observed in any of the treated animals at 4, 24 h and up to
14 days after treatment.
Mice in both, vehicle treated and SMEAF treated groups
were found to be normal and no significant changes were dis-
played in behavior, skin effect, hair loss, breathing, and postu-
ral abnormalities. Among the SMEAF treated group, after 2 h
a slightly higher defecation was observed. This defecation, con-
tinued till 4 h and then was discontinued. The probable reason
for defecation in animals could be the stress and fear of receiv-
ing the oral administration of the extract.
The data for body weight of the animals are shown in
Fig. 1. No significant changes were observed in the body
weight of the mice administered with SMEAF as compared
to the control group. All the mice showed a normal incrementhyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection
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Figure 1 Body weights of mice during 14 days of study (n= 6).
Data are expressed as mean ± SEM and analyzed by t-test
(p< 0.05) as compared to that of the control group.
Figure 2 Food intake of mice during 14 days of study (n= 6).
Data are expressed as mean ± SEM and analyzed by t-test
(p< 0.05) as compared to that of the control group.
Figure 3 Water intake of mice during 14 days of study (n= 6).
Data are expressed as mean ± SEM and analyzed by t-test
(p< 0.05) as compared to that of the control group.
Figure 4 Organ weight of mice after 14 days of study (n= 6).
Data are expressed as mean ± SEM and analyzed by t-test
(p< 0.05) as compared to that of the control group.
Table 1 Hematology values of mice treated with control and
SMEAF 2000 mg/kg (means ± SEM).
Control SMEAF treated
Complete blood count (CBC)
HGB (g/L) 163.50 ± 0.96 163.75 ± 2.14
HCT (L/L) 0.57 ± 0.01 0.56 ± 0.01
RBC (1012/L) 10.44 ± 0.13 9.77 ± 0.25
MCV (fl) 53.50 ± 0.87 50.50 ± 1.32
MCH (pg) 15.48 ± 0.13 15.75 ± 0.10
MCHC (g/L) 293.00 ± 1.08 290.00 ± 2.74
RDW (%) 20.93 ± 0.19 19.50 ± 0.15
WBC (109/L) 9.30 ± 0.40 6.08 ± 0.14
Platelet (109/L) 1063.00 ± 61.98 963.50 ± 13.07
Diﬀerential count
Neutrophil (109/L) 0.91 ± 0.16 0.55 ± 0.02
Lymphocyte (109/L) 8.15 ± 0.72 5.41 ± 0.21
Monocyte (109/L) 0.07 ± 0.02 0.01 ± 0.00
Eosinophil (109/L) 0.01 ± 0.00 0.00 ± 0.00
Basophil (109/L) 0.03 ± 0.01 0.02 ± 0.00
Immature granulocyte (109/L) 0.00 ± 0.00 0.00 ± 0.00
n= 6, analyzed by t-test, significantly different from the control
group: *P 6 0.05.
4 M. Sayyad et al.in the body weight in both control and SMEAF treated
groups. The difference for the first 3 days is observed to have
a wide range in the representative graph. However, the valuesPlease cite this article in press as: Sayyad, M. et al., Acute toxicity profiling of the et
studies. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.0of the mean body weights were found to be 19 and 20 g, for
control and SMEA extract groups, respectively. This differ-
ence was found to be statistically insignificant.
The results for food and water intake, between extract trea-
ted mice and control mice groups are shown in Figs. 2 and 3
respectively. No significant changes in food and water intake
were observed between both the groups throughout the exper-
iment period, which indicates that SMEAF has no toxic
effects. The difference in the food and water intake was found
to be significant on 6th and 7th day only. This trend was not
observed again during the study. The probable reason for such
observation could possibly be environmental factors. The
impact of environmental factors such as light, noise, cage
cleaning and in-house transport on welfare and stress of labo-
ratory rats is well reported (Castelhano-Carlos and Baumans,
2009).hyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection
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Table 2 Biochemical parameters of mice treated with control
and SMEAF 2000 mg/kg (means ± SEM).
Control SMEAF
treated
Renal function test
Sodium (mmol/L) 150.25 ± 0.25 146.67 ± 0.33
Potassium (mmol/L) 6.48 ± 0.30 7.13 ± 0.30
Chloride (mmol/L) 113.00 ± 0.91 111.67 ± 1.20
Carbon dioxide (mmol/L) 22.25 ± 1.03 21.33 ± 1.20
Anion gap (mmol/L) 21.50 ± 0.29 21.33 ± 2.03
Urea (mmol/L) 8.18 ± 0.30 7.60 ± 0.67
Creatinine (umol/L) 18.75 ± 0.48 19.67 ± 0.88
Liver function test
Total protein (g/L) 51.25 ± 0.75 51.00 ± 1.16
Albumin (g/L) 32.25 ± 0.48 32.00 ± 0.58
Globulin (g/L) 19.00 ± 0.41 19.00 ± 0.58
Total bilirubin (umol/L) 2.00 ± 0.00 2.00 ± 0.00
Conjugated bilirubin (umol/L) 1.00 ± 0.00 1.00 ± 0.00
Alkaline phosphatase (U/L) 159.75 ± 15.05 152.67 ± 4.92
Alanine aminotransferase
(U/L)
41.25 ± 2.69 61.00 ± 17.06
AST (U/L) 152.50 ± 29.69 230.33 ± 73.35
G-glutamyl transferase (U/L) 2.00 ± 0.41 2.67 ± 0.88
n= 6, analyzed by t-test, significantly different from the control
group: *P 6 0.05.
Toxicity study and neuroprotective activity of Swietenia macrophylla 53.3. Macroscopic observations and weight of the organs
The vital organs were grossly observed for their appearance,
size and color and compared between control and SMEAF
treated mice. No significant changes were observed in the
absolute and relative organ weight of seven principle organs
in SMEAF group when compared to the vehicle control. The
major organ weights are shown in Fig. 4. There were no signs
of the toxicity and no significant differences in the appear-
ance; size and color of the organs of the SMEAF treatedTable 3 Necropsy findings after oral treatment of SMEAF 2000 m
Organs/groups Condition
Brain Normal
Abnormality detected
Heart Normal
Abnormality detected
Lungs Normal
Abnormality detected
Kidney Normal
Abnormality detected
Liver Normal
Abnormality detected
Spleen Normal
Abnormality detected
Testes Normal
Abnormality detected
a The values stated are indicated for 6 mice per group, as observed ani
Please cite this article in press as: Sayyad, M. et al., Acute toxicity profiling of the et
studies. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.0mice as compared to the control mice. Liver weights of
SMEA treated group appeared to be higher compared to
the control group. One of the considerable reasons for this
is the difference in the body weights of the animals. When
liver weight was checked with respect to body weight of
the animals, they were found to be in equal ratio. In order
to confirm whether this liver weight is because of liver toxic-
ity (fatty liver), histopathological studies were conducted, and
liver sections were found to exhibit normal tissue
characteristics.
3.4. Hematology and blood biochemistry
There were no significant differences in the complete blood
count and differential count of cells between SMEAF treated
and control groups. Hematology results are shown in Figs. 7
and 8. No changes were observed in parameters pertaining
to liver and kidney functions between animals belonging to
SMEAF and the control group. Results for serum biochem-
istry, are shown in Tables 1 and 2.
3.5. Necropsy and histopathological analysis
There were no significant changes on the gross morphology of
seven principal organs of animals treated with SMEAF, com-
pared to the control group animals. The obtained results are
shown in Table 3.
In histopathological analysis, autopsy at the end of the
study revealed no apparent changes in all major organs of
the animals belonging to both the control and treated groups.
The microscopic structure of the organs (illustrated in Figs. 5–7)
indicates no significant structural differences between the control
and SMEAF groups. When viewed under the light microscope
using various magnification powers, no alteration in the cell
structure was observed in all the organs from both the groups.
The structure of cells was found to be identical in the organs
of the extract treated animals when compared with organs of
control group animals.g/kg.
Control (vehicle)a SMEAF 2000 mg/kga
6/6 6/6
0/6 0/6
6/6 6/6
0/6 0/6
6/6 6/6
0/6 0/6
6/6 6/6
0/6 0/6
6/6 6/6
0/6 0/6
6/6 6/6
0/6 0/6
6/6 6/6
0/6 0/6
mals/total observed animals.
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Figure 5 Histopathological observations of heart, liver and lungs of experimental animals: A1 and A2 represent sections of heart of
control group and SMEAF treated animals. No change in nucleus of myocyte, myocardium, and blood vessels was observed; B1 and B2
represent sections of liver of control group and SMEAF treated animals. No structural changes in hepatocytes, portal triad and central
vein between the two study groups were observed. C1 and C2 represent sections of lungs of control group and SMEAF treated animals.
No structural changes in pulmonary vessel, bronchiole, and alveoli in both the treated and control groups were observed.
6 M. Sayyad et al.3.6. Neuroprotective effects of SMEAF against TBHP induced
oxidative stress
In the present study, the neuroprotective effect of SMEAF was
examined with the TBHP-induced oxidative stress model using
primary cortex neuronal cell. The neuroprotective effect of
SMEAF was evaluated by MTT assay. The results (as
observed in Fig. 8) indicate that, increasing concentration of
SMEAF resulted in a substantial improvement in viability of
cells when compared with TBHP treated cells, up to 30 lg/
mL concentration. The results obtained, thus provide evidence
of SMEAF exhibiting significant neuronal protective effect
against the damage caused by oxidation.
4. Discussion
Since past few decades, phytochemical compounds have been
extensively used for therapeutic applications due to theirPlease cite this article in press as: Sayyad, M. et al., Acute toxicity profiling of the et
studies. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.0benefits and because they are considered to have minimal, or
no side effects (Abdel-Rahman et al., 2012; Brinker, 1983).
However, it is of utmost importance to evaluate the toxic
effects of the plant materials, extracts and phytoconstituents
before being administered for systemic use. Thus, there is a
need to establish the safety profiles of the plant based extracts
and compounds, considering their possible short term and long
term adverse effects (Sarma et al., 2008). In general, acute tox-
icity studies provide valuable information about the lethal dose
and safe dose range of the plant extracts. These studies provide
valuable information for further evaluation of pharmacologi-
cal properties of traditional plant based medicines (Hasani-
Ranjbar et al., 2010; Palombo, 2011).
The in-vitro assay was performed to determine the potential
for possible neuroprotection of SMEAF which can serve as a
basis for future in-vivo pharmacological studies (Fakeye
et al., 2009). The present study demonstrated the efficacy of
selected extracts against cellular toxicity and the viability of
primary neuronal cells against TBHP induced oxidative stress.hyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection
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Figure 6 Histopathological observations of spleen, kidneys and testes of experimental animals: D1 and D2 represent spleen of control
and SMEAF treatment groups. E1 and E2 represent kidneys of control and SMEAF treatment groups. F1 and F2 represent testes of
control and SMEAF treatment groups. No distinct structural differences were observed in the structure of the cells in both the treated and
control groups.
Toxicity study and neuroprotective activity of Swietenia macrophylla 7The current study established the acute toxicity effect of
SMEAF in male Balb–c mice, which is known to be a better
animal model compared to rats for prediction of human
LD50 dose (Walum et al., 1995).
In toxicity studies, any untoward clinical symptoms in mice
indicate the toxicity of the organs in the treated groups (Eaton
and Klaassen, 1996). Mice orally administrated with SMEAF
2000 mg/kg showed no clinical signs of distress, and there were
no noticeable symptoms of toxicity or mortality during 14 days
of the study period. All the animals followed normal weight
and behavior pattern with no significant changes between the
groups. Also, no change was observed in physical appearance
features such as eyes, fur and skin which were found to be nor-
mal while there was a normal increase in the body weight of
the animals (Fig. 2). This indicates that, the administration
of the SMEAF extract has no adverse effects on the growth
of the animals (Jothy et al., 2011; Stevens and Mylecraine,
1994). The food and water intake was also not affected byPlease cite this article in press as: Sayyad, M. et al., Acute toxicity profiling of the et
studies. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.0the administration of SMEAF. Thus we can infer that, the
extract did not induce appetite suppression, which is an indica-
tion of normal carbohydrate, protein or fat metabolism (Jothy
et al., 2011; Stevens and Mylecraine, 1994; Klassen, 2013).
Significant loss in body weight of animals up to 10% of ini-
tial body weight, with the administration of extract is consid-
ered as toxic for its use. Also, organ weight is a more
specific index of physiological and pathological status of ani-
mals (Auletta, 1995; Raza et al., 2002). In our study, no
changes were noticed in gross observations of the primary
organs from both the groups.
Our results support the basis of safety of SMEAF extract,
with LD50 value greater than 2000 mg/kg (Dybing et al.,
2002). According to the chemical labeling and classification
of acute oral toxicity guidelines prescribed by OECD, the
SMEAF falls under the lowest toxicity class
(LD50 > 2000 mg/kg). The extracts with LD50 values higher
than 2000 mg/kg via oral route are considered safe andhyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection
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Figure 7 Histological examination of brain sections of experimental animals at 4 and 20 magnification. G1 represents sections of
control group animals and G2 represents sections of SMEAF treated animals. (a represents cortex and b represents hippocampus CA3
region.)
8 M. Sayyad et al.practically non-toxic (Roopashree, 2009; Balijepalli et al.,
2015). The histological examination is the basis for establishing
treatment related pathological changes in cell structures of
organs (Balijepalli et al., 2015). In this study, histological
examination has revealed, no structural changes in the cell
structure of the organs of experimental animals. The liver is
considered as a primary target organ for acute toxicity due
to the first step in first pass metabolism (Co-operation and
Development, 1995). Examination of liver tissues has shown
normal hepatocytes and no changes in the structure of the cells
between groups (Fig. 5B1 and B2). No inflammatory changes,
necrosis, fibrosis or local fatty degeneration was observed in
the liver (Salawu et al., 2009).Please cite this article in press as: Sayyad, M. et al., Acute toxicity profiling of the et
studies. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.0Microscopic study of the heart and spleen (Fig. 5A1 and
A2; and Fig. 6D1 and D2) of the animals treated with SMEAF
showed no changes in the organ tissue compared to the control
group. The spleen tissues from both the groups were normal,
with well labeled white and red pulp. The hematopoietic sys-
tem is very sensitive to the effect of toxic compounds and it
serves as an important factor to determine toxicity in animals
(Akanmu et al., 2004). At the end of study period, the hema-
tological parameters were similar for both the groups except
for the WBC count. The values for the WBC count of the con-
trol and SMEAF treated were 9.30 ± 0.40 and 6.08 ± 0.40
respectively, and they were still found to be within the refer-
ence range. In the differential count, low levels of neutrophils,hyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection
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Figure 8 Effect of SMEAF on TBHP treated cell viability in
primary neuronal culture (n= 6) at 1 lg/mL, 10 lg/mL and
30 lg/mL concentrations. Data are expressed as Mean ± SEM
and analyzed by ANOVA, followed by Dunnet’s test (*p< 0.05;
**p< 0.01; ***p< 0.001) for each concentration with respect to
the TBHP treated group.
Toxicity study and neuroprotective activity of Swietenia macrophylla 9lymphocytes and monocytes counts were observed in both the
control and treatment groups (Diana et al., 2003). The results
also indicate that, SMEAF extract did not alter serum levels of
ALP, and TBIL.
5. Conclusion
The in-vitro data suggest, SMEAF has significant protective
effects against TBHP induced oxidative stress and it possesses
neuroprotective activity. The results obtained in our study
demonstrate that, SMEAF does not produce any in-vivo toxi-
city at the dose of 2000 mg/kg, thus demonstrating its potential
safety in systemic use. However, further explorative studies are
required for evaluation of its chronic toxicity and pharmaco-
logical benefits, in order to be considered safe and beneficial
for therapeutic use.
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